Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
Oncotelic Therapeutics [US6283411097]   
[14/12/2021]

Oncotelic Therapeutics : Oncotelic's Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022

DGAPNews: Oncotelic Therapeutics Oncotelics Dr. Anthony Maida to Present at 2nd Annual TGFβ for ImmunoOncology Drug Development Summit in January 2022 14.12.2021 / 15:01 The issuer is solely responsible for the content of this announcement.... Lire le communiqué
 
Oncotelic Therapeutics [US6283411097]   
[23/11/2021]

Oncotelic Therapeutics : ONCOTELIC ANNOUNCES POSITIVE TOPLINE DATA FOR OT-101 C001 COVID STUDY

DGAPNews: Oncotelic Therapeutics ONCOTELIC ANNOUNCES POSITIVE TOPLINE DATA FOR OT101 C001 COVID STUDY 23.11.2021 / 13:00 The issuer is solely responsible for the content of this announcement.... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de Oncotel...